Complex formation between Mad1p, Bub1p and Bub3p is crucial for spindle checkpoint function  by Brady, D.Michelle & Hardwick, Kevin G.
Brief Communication 675
Complex formation between Mad1p, Bub1p and Bub3p is crucial
for spindle checkpoint function
D. Michelle Brady and Kevin G. Hardwick 
The spindle checkpoint delays the metaphase to
anaphase transition in response to defects in
kinetochore–microtubule interactions in the mitotic
apparatus (see [1–4] for reviews). The Mad and Bub
proteins were identified as key components of the
spindle checkpoint through budding yeast genetics [5,6]
and are highly conserved [3]. Most of the spindle
checkpoint proteins have been localised to kinetochores,
yet almost nothing is known about the molecular events
which take place there. Mad1p forms a tight complex with
Mad2p [7], and has been shown to recruit Mad2p to
kinetochores [8]. Similarly, Bub3p binds to Bub1p [9]
and may target it to kinetochores [10]. Here, we show
that budding yeast Mad1p has a regulated association
with Bub1p and Bub3p during a normal cell cycle and
that this complex is found at significantly higher levels
once the spindle checkpoint is activated. We find that
formation of this complex requires Mad2p and Mps1p
but not Mad3p or Bub2p. In addition, we identify a
conserved motif within Mad1p that is essential for
Mad1p–Bub1p–Bub3p complex formation. Mutation of
this motif abolishes checkpoint function, indicating that
formation of the Mad1p–Bub1p–Bub3p complex is a
crucial step in the spindle checkpoint mechanism. 
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Results and discussion
Analysis of Mad1p immunoprecipitates revealed a regulated
association with Bub1p and Bub3p (Figure 1). Wild-type
cells were arrested in G1 phase with α factor, washed and
then released into fresh media in the presence or absence of
nocodazole for time course analyses. Mad1p immunoprecip-
itates from the nocodazole-treated cells (Figure 1a, left
panel) revealed that a Mad1p–Bub1p–Bub3p complex was
formed 40 minutes after release from an α-factor arrest and
was then maintained. A constant level of Mad2p was asso-
ciated with Mad1p, in agreement with published work [7].
During a normal cell cycle, one that was unperturbed by
anti-microtubule disrupting agents, there was only a brief
period in the cell cycle (40–60 minutes after α factor
release) in which Bub1p and Bub3p were found associ-
ated with Mad1p (Figure 1a, right panel). We suggest
that this is the period in the budding yeast cell cycle in
which the newly replicated centromeres have yet to form
stable kinetochore–microtubule interactions. Budding
yeast is unusual in that it forms a bipolar spindle rela-
tively early in the cell cycle while DNA is still being
replicated. Budding yeast centromeres are replicated
early in S phase [11] and it has recently been shown that
they separate before replication of the chromosome arms
is completed [12]. Thus, replicated sister kinetochores
could be in the process of forming bipolar spindle attach-
ments at the time Mad1p–Bub1p–Bub3p complex forma-
tion was detected. To our knowledge, this is the first
biochemical indication that the budding yeast spindle
checkpoint is activated every cell cycle.
To confirm that complex formation was due to spindle
checkpoint activation, rather than cell cycle position, we
compared Mad1p–Bub1p–Bub3p levels in a nocodazole-
induced ‘metaphase’ arrest with a cdc26∆ metaphase arrest.
cdc26∆ cells arrest at metaphase at their restrictive tempera-
ture due to an inactive anaphase promoting complex
(APC) [13,14]. Whereas high levels of Mad1p–Bub1p–Bub3p
were detected in nocodazole arrested cells, very little was
found in the cdc26∆ metaphase arrest where spindle micro-
tubules would be attached to kinetochores (Figure 1b).
We also analysed time courses for the abundance and modi-
fication of Bub1p and Bub3p (Figure 2 and see Supplemen-
tary material). In G1 phase, there were two distinct forms of
Bub1p, whereas in mitotic samples five forms could be sep-
arated by SDS–PAGE (see Figure 2a). Lambda protein
phosphatase treatment of Bub1p immunoprecipitates
showed that those forms of Bub1p were the result of phos-
phorylation (Figure 2b). Bub1p modification was not
enhanced by checkpoint activation, as a similar level of
modification was seen in both nocodazole and cdc26∆-
arrested cells (Figures 1b and 2b). We detected similar
modification of Bub1p in synchronous cultures passing
through an unperturbed mitosis, found no evidence of
Bub3p modification, and found that Bub3p was associated
with Bub1p throughout the cell cycle (see Supplementary
material). Thus, formation of the Mad1p–Bub1p–Bub3p
complex does not simply reflect changes in levels of Bub1p
or Bub3p. This Mad1p–Bub1p–Bub3p interaction contrasts
with a number of other Mad–Bub protein complexes
which are not cell cycle regulated (Mad1p-Mad2p [7],
Bub1p-Bub3p (see Supplementary material), and Mad3p-
Bub3p [15]), suggesting that it may be an important step in
spindle checkpoint function.
To determine which of the other known spindle checkpoint
components are necessary for the Mad1p–Bub1p–Bub3p
interaction, we carried out anti-Mad1p and anti-Bub1p
immunoprecipitations from extracts of nocodazole-treated
checkpoint mutants.  Mad2p, Bub3p and Mps1p functions
were necessary for formation of a stable Mad1p–Bub1p
complex, but Bub2p and Mad3p functions were not
(Figure 3 and see Supplementary material). Similar Mad1p
co-immunoprecipitations revealed that Mad2p, Bub1p and
Mps1p functions were required for the Mad1p–Bub3p asso-
ciation (data not shown). We found that very little, if any,
Mad2p was associated with the Mad1p–Bub1p–Bub3p
complex (data not shown). The simplest interpretation of
our results is that a Mad1p–Bub1p–Bub3p complex is
formed in yeast cells upon spindle checkpoint activation
and that the functions of Mps1p and Mad2p are required for
its formation. Perhaps in the absence of Mad2p, Mad1p
does not efficiently localise to kinetochores, and it is only
there that the Mad1p–Bub1p–Bub3p complex can be
formed? The Mps1 requirement suggests that either Mad1p
or Bub1p, or both, need to be phosphorylated for the
complex to be efficiently formed and/or stabilised. Further
investigation will be required to address these targetting
and phosphorylation issues.
Seeley et al. have shown that the human Mad1 protein
binds to and is phosphorylated by the human Bub1 kinase
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Figure 1
Mad1p forms a complex with Bub1p and
Bub3p which is cell cycle regulated. (a) Wild-
type yeast cells containing Myc-tagged
Bub3p (KH 228) were synchronised in G1
phase with the mating pheromone α factor
and then released into rich growth media with
and without the addition of 15 µg/ml
nocodazole, a microtubule-disrupting agent.
Immunoblot analysis of whole cell extracts
revealed cell cycle position (the mitotic cyclin,
Clb2p, is high in mitosis) and that Mad1p was
phosphorylated in the nocodazole-treated
cells. Analysis of anti-Mad1p
immunoprecipitates revealed that although
Mad2p was always associated with Mad1p,
there was a regulated association between
Mad1p and the Bub proteins. Bub3p
(anti-Myc) and Bub1p were detected in the
anti-Mad1p immunoprecipitates from 40 min
to 60 min of the unperturbed cell cycle, and at
significantly higher levels in the
nocodazole-treated cells from 40 min onwards.
(b) Bub3p was immunoprecipitated, using
coupled anti-Myc antibodies, from whole cell
extracts made from cells arrested in G1 (with
α factor), in mitosis (with nocodazole, which
activates the spindle checkpoint), or at
metaphase (by shifting cdc26∆ mutants to
their restrictive temperature of 37°C, which
does not activate the spindle checkpoint).
Bub1p was always detectable in the
anti-Bub3p immunoprecipitates, but
Mad1p could be detected only in the
nocodazole- arrested cells.
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Figure 2
Bub1p is phosphorylated in a cell cycle
dependent manner. (a) Time course analysis
of Bub1p modification through the cell cycle.
Cells arrested with α factor were washed and
released into media containing nocodazole.
Bub1p immunoprecipitates were
immunoblotted with anti-Bub1p antibodies
(upper panel), and whole cell extracts were
probed with anti-Clb2p antibodies (lower
panel). Two distinct forms of Bub1p were
detected in G1 phase, and four or five in
mitosis. Similar levels of Bub1p modification
were detected in synchronous cells passing
through mitosis (see Supplementary
material). (b) Bub1p was immunoprecipitated
from cells arrested with α factor, nocodazole
and an APC mutation (cdc26∆) and treated
with lambda protein phosphatase (λPPase).
The immunoprecipitates were then
immunoblotted for Bub1p to reveal that all
the slower migrating forms of Bub1p were
the result of phosphorylation. 
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in vitro [16]. This work and an analysis of recombinant
mouse Bub3 [17] showed that whilst recombinant Bub1
was associated with Bub3, its kinase activity is not stimu-
lated by this interaction, nor is Bub3 a substrate in
immunoprecipitated Bub1 kinase assays. In addition, it was
shown that although Bub3 is associated with the
Mad1–Bub1 complex, Mad2 is not [16]. Thus, in vitro
experiments using recombinant mammalian proteins are
entirely in agreement with our immunoprecipitation analy-
ses of native complexes from yeast extracts. Our budding
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Figure 3
Formation of the Mad1p–Bub1p–Bub3p
complex depends on the functions of Mad2p
and Mps1p. (a) The indicated strains were
treated with nocodazole for 3 h before
extracts were made and Bub1p was
immunoprecipitated. The immunoprecipitates
were then immunoblotted with anti-Bub1p,
anti-Bub3p and anti-Mad1p antibodies. Unlike
the Bub1p–Bub3p interaction, the
Bub1p–Mad1p complex was found to require
Mad2p, Bub3p and Mps1p functions.
(b) Overexpression of Mps1p leads to
Mad1p–Bub1p complex formation, and the
kinase activity of Bub1p is not necessary for
complex formation. Strains containing
GAL–MPS1 and either wild-type BUB1
(lanes 1,2) or kinase-dead bub1 (lanes 3,4)
were grown in dextrose (lanes 1,3) or
galactose (lanes 2,4) for 6 h to induce the
expression of MPS1. Immunoblotting of
anti-Mad1p immunoprecipitates revealed an
association of both wild-type and mutant
Bub1 kinase with Mad1p, although the
interaction was reduced by the kinase-dead
mutation. Lane 5 is a control indicating the
levels of complex formed in wild-type cells
after 3 h of nocodazole treatment.
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Vector
ScMad1   FELKQFEQEVFKSNKRFSRLKQVFNNKSLEFIDVVNSFLGFKLEFQQDSRVKIFSCFKPE
SpMad1   RKALDLKKEVAEREKRIQRLKEIFSVKSLEFREAVFSLFGYKLDFMPNGSVRVTSTYSRE
XlMad1   QELAELKKQVESAELKNQRLREVFQTKIHEFRTACYMLTGYRIDITTENQYRLTSMYGEH
HsMad1   KEVAELKKQVESAELKNQRLKEVFQTKIQEFRKACYTLTGYQIDITTENQYRLTSLYAEH
ScMad1   ....KYLIADLNENTLKSNLDADIEG.WDDLMNLWVEDRGQLPCFLATITLRLWEQRQAK
SpMad1   ..DNTAFIFDGES.STMKLVGNPSGPEFERLIRFWCDERKTIPGMLAALTLELLDKND..
XlMad1   KEDNLLFKASGSSGGKMQLLETDFSLTLRDFIDLHLHHQNSIPAFLSAVTLDLFSRQTFA
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Identification of a conserved motif in Mad1p that is required for
Mad1p–Bub1p–Bub3p complex formation and checkpoint function.
(a) A Clustal alignment of the carboxyl termini of Mad1p from budding
yeast (Sc), fission yeast (Sp), Xenopus laevis (Xl), and human (Hs).
The asterisks mark the site-directed RLK-AAA mutation. (b) The RLK
mutant is unable to rescue a mad1∆ strain. A mad1∆ strain was
transformed with plasmids containing wild-type MAD1, the mad1 RLK-
AAA mutant, or an empty vector. Transformants were then spotted, at
three dilutions, onto rich growth media (YPD) with or without
12.5 µg/ml of the microtubule-disrupting drug benomyl (Ben), and
photographed after 3 days growth at 23°C. Microcolony assays
confirmed that the mad1 RLK-AAA mutant has a checkpoint defect
(data not shown). (c) The mad1 RLK-AAA mutant is stable and binds
Mad2p, but is unable to bind either Bub1p or Bub3p. Mad1p was
immunoprecipitated from strains containing either the wild-type or RLK
mutant protein, and the immunoprecipitates were then separated by
SDS–PAGE and immunoblotted with antibodies to Mad1p, Mad2p,
Bub1p and Bub3p (anti-Myc). 
yeast analysis has shown that a Mad1p–Bub1p–Bub3p
complex is formed in vivo, revealed a requirement for both
Mad2p and the Mps1 kinase in its formation, and provided
information about its cell cycle regulation.
Is Bub1p’s kinase activity necessary for in vivo formation
of the Mad1p–Bub1p complex? Strains were constructed
in which the only copy of BUB1 was the previously
described bub1K733R kinase-dead mutant [9]. Two types
of experiment were carried out: the spindle checkpoint
was activated by overexpression of the Mps1 protein
kinase [18] (Figure 3b), and the spindle checkpoint was
activated by nocodazole treatment (data not shown). In
both cases, Mad1p immunoprecipitates were found to
contain kinase-dead Bub1p, but it was present at lower
levels than wild-type Bub1p. These experiments show
that the kinase activity of Bub1p is not absolutely required
for its complex formation with Mad1p. In addition, an
alternative means of checkpoint activation, overexpression
of the Mps1 protein kinase, also led to Mad1p–Bub1p
complex formation (Figure 3b). 
What is the importance of Mad1p–Bub1p–Bub3p complex
formation for spindle checkpoint function? Comparison of
Mad1p homologues from several species revealed that there
is little homology at the primary amino-acid sequence level
[8,19]. What little conservation there is lies towards the car-
boxyl terminus of Mad1p, which has been implicated in
Mad2p binding [7]. We mutated a highly conserved
sequence motif Arg-Leu-Lys to alanines (Figure 4a) and
found that this mutant version of Mad1p (RLK-AAA) con-
ferred a checkpoint defect (Figure 4b). Co-immunoprecipi-
tations revealed that this mutation had no effect on the
ability of the protein to bind to Mad2p, but that it did not
co-immunoprecipitate with Bub1p or Bub3p (Figure 4c).
This conserved region of Mad1p is therefore crucial for its
Bub1p–Bub3p interaction and the mutation shows that such
an interaction is necessary for Mad1p’s checkpoint function.
Checkpoint proteins bind to kinetochores that have not
yet bound microtubules [20,21], and/or to kinetochores
not under tension [22]. They then transmit a signal
throughout the mitotic apparatus which inhibits Cdc20p
function [23,24]. As Cdc20p, the spindle checkpoint effec-
tor, is not present in the Mad1p–Bub1p–Bub3p complex
(data not shown), we propose that, rather than being directly
involved in Cdc20p inhibition, the Mad1p–Bub1p–Bub3p
complex has an upstream signalling function. Further work
will be necessary to determine how formation of this
complex leads to the inhibition of Cdc20p (see model in
Supplementary material).
Supplementary material
Supplementary material including a time-course of Bub1p and
Bub3p expression, data showing that formation of the
Mad1p–Bub1p–Bub3p complex is dependent on the functions of
Mad2p and Mps1p, a model of Mad1p–Bub1p–Bub3p complex
function within the spindle checkpoint and additional methodological
details is available at http://current-biology.com/supmat/supmatin.htm.
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